Shu‐Hsing Cheng

3.1k total citations
67 papers, 979 citations indexed

About

Shu‐Hsing Cheng is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Shu‐Hsing Cheng has authored 67 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 38 papers in Epidemiology and 16 papers in Hepatology. Recurrent topics in Shu‐Hsing Cheng's work include Hepatitis B Virus Studies (18 papers), HIV/AIDS drug development and treatment (15 papers) and Hepatitis C virus research (15 papers). Shu‐Hsing Cheng is often cited by papers focused on Hepatitis B Virus Studies (18 papers), HIV/AIDS drug development and treatment (15 papers) and Hepatitis C virus research (15 papers). Shu‐Hsing Cheng collaborates with scholars based in Taiwan, South Korea and United States. Shu‐Hsing Cheng's co-authors include Chien‐Yu Cheng, Fang‐Yeh Chu, Fu‐Hsiung Su, Cheng‐Pin Chen, Ding‐Shinn Chen, Chih‐Yuan Wang, Chin‐Yun Lee, Hui‐Ling Hsu, Yu‐Mei Hsueh and Chien‐Ching Hung and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Shu‐Hsing Cheng

63 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Hsing Cheng Taiwan 16 644 443 356 83 79 67 979
Valérie Martel‐Laferrière Canada 17 573 0.9× 373 0.8× 503 1.4× 37 0.4× 35 0.4× 74 1.0k
Firouzé Bani‐Sadr France 20 742 1.2× 502 1.1× 660 1.9× 80 1.0× 107 1.4× 129 1.4k
Déborah Konopnicki Belgium 14 858 1.3× 362 0.8× 370 1.0× 215 2.6× 97 1.2× 46 1.3k
É. Rouveix France 15 458 0.7× 464 1.0× 122 0.3× 78 0.9× 184 2.3× 77 948
David Witt United States 9 589 0.9× 214 0.5× 102 0.3× 28 0.3× 38 0.5× 16 771
Mojca Matičič Slovenia 17 781 1.2× 491 1.1× 592 1.7× 122 1.5× 48 0.6× 81 1.4k
Patrick Miailhes France 24 995 1.5× 383 0.9× 862 2.4× 68 0.8× 134 1.7× 82 1.4k
Marie‐Luce Delforge Belgium 18 582 0.9× 563 1.3× 145 0.4× 35 0.4× 155 2.0× 48 999
Marcello Piazza Italy 18 432 0.7× 300 0.7× 451 1.3× 84 1.0× 176 2.2× 38 953
Victoria Aramă Romania 15 300 0.5× 218 0.5× 82 0.2× 116 1.4× 38 0.5× 97 610

Countries citing papers authored by Shu‐Hsing Cheng

Since Specialization
Citations

This map shows the geographic impact of Shu‐Hsing Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Hsing Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Hsing Cheng more than expected).

Fields of papers citing papers by Shu‐Hsing Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Hsing Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Hsing Cheng. The network helps show where Shu‐Hsing Cheng may publish in the future.

Co-authorship network of co-authors of Shu‐Hsing Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Hsing Cheng. A scholar is included among the top collaborators of Shu‐Hsing Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Hsing Cheng. Shu‐Hsing Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Han‐Chieh, Nan Jiang, Shu‐Hsing Cheng, et al.. (2025). Multiplex metagenomic sequencing for rapid viral pathogen identification and surveillance in clinical specimens. BMC Infectious Diseases. 25(1). 1531–1531.
3.
Chen, Wen‐Jone, et al.. (2025). Risk factors for mpox infection among MSM with STIs in northern Taiwan, 2022–2024. Journal of Infection and Chemotherapy. 31(8). 102750–102750.
4.
Lin, Yi‐Chun, Cheng‐Pin Chen, Shu‐Hsing Cheng, et al.. (2024). IoT‐Based Hand Hygiene Compliance Monitoring System and Validation of Its Effectiveness in Hospital Environments. SHILAP Revista de lepidopterología. 8(12). 2400124–2400124. 1 indexed citations
5.
Hou, Yueh‐Ju, Yu‐Shan Huang, Chia-Lin Chiu, et al.. (2023). Rapid Escherichia coli Cloned DNA Detection in Serum Using an Electrical Double Layer-Gated Field-Effect Transistor-Based DNA Sensor. Analytical Chemistry. 95(17). 6871–6878. 6 indexed citations
6.
Huang, Yi‐Chia, Chia‐Jui Yang, Hsin‐Yun Sun, et al.. (2023). Comparable clinical outcomes with same-day versus rapid initiation of antiretroviral therapy in Taiwan. International Journal of Infectious Diseases. 140. 1–8. 4 indexed citations
7.
Chen, Cheng‐Pin, Kuan-Ying A. Huang, Shin‐Ru Shih, et al.. (2022). Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants. Microbiology Spectrum. 10(4). e0074322–e0074322. 4 indexed citations
8.
Cheng, Shu‐Hsing, Chia-En Lien, Szu‐Min Hsieh, et al.. (2022). A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV. Vaccines. 11(1). 18–18. 5 indexed citations
9.
Lin, Yi‐Chun, Yu-Lin Lee, Chien‐Yu Cheng, et al.. (2021). Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan. Journal of Microbiology Immunology and Infection. 54(5). 816–829. 8 indexed citations
10.
Lin, Mei‐Hui, et al.. (2020). Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study. The Journal of Infection in Developing Countries. 14(8). 901–907. 1 indexed citations
11.
Li, Chia‐Wen, Chia‐Jui Yang, Hsin‐Yun Sun, et al.. (2018). Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan. PLoS ONE. 13(3). e0194149–e0194149. 18 indexed citations
12.
Cheng, Shu‐Hsing, et al.. (2018). Multiple types of human papillomavirus infection and anal precancerous lesions in HIV-infected men in Taiwan: a cross-sectional study. BMJ Open. 8(1). e019894–e019894. 11 indexed citations
13.
Lee, Yu-Lin, Kuan‐Yin Lin, Chien‐Yu Cheng, et al.. (2017). Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan. PLoS ONE. 12(10). e0186338–e0186338. 14 indexed citations
14.
Lin, Kuan‐Yin, Chien‐Yu Cheng, Chia‐Jui Yang, et al.. (2014). Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: Incidence and associated factor. Journal of Infection and Chemotherapy. 20(8). 465–470. 4 indexed citations
15.
Cheng, Chien‐Yu, Yu‐Zhen Luo, Pei‐Ying Wu, et al.. (2014). Antiretroviral therapy (ART) management of Low‐Level Viremia in Taiwan (ALLEVIATE). Journal of the International AIDS Society. 17(4S3). 19785–19785. 5 indexed citations
16.
Cheng, Shu‐Hsing, Chin-Hui Yang, & Yu‐Mei Hsueh. (2013). Highly Active Antiretroviral Therapy is Associated with Decreased Incidence of Sexually Transmitted Diseases in a Taiwanese HIV-Positive Population. AIDS Patient Care and STDs. 27(3). 155–162. 5 indexed citations
17.
18.
Cheng, Shu‐Hsing, et al.. (2007). Gender Difference in the Clinical and Behavioral Characteristics of Human Immunodeficiency Virus-infected Injection Drug Users in Taiwan. Journal of the Formosan Medical Association. 106(6). 467–474. 8 indexed citations
19.
Su, Fu‐Hsiung, Jong‐Dar Chen, Shu‐Hsing Cheng, et al.. (2006). Seroprevalence of Hepatitis‐B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis‐B vaccination program. Journal of Medical Virology. 79(2). 138–143. 54 indexed citations
20.
Hsu, Hui‐Ling, et al.. (1988). Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers.. PubMed. 260(15). 2231–5. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Martel‐Laferrière Breakdown of academic impact, for papers by Firouzé Bani‐Sadr Breakdown of academic impact, for papers by Déborah Konopnicki Breakdown of academic impact, for papers by É. Rouveix Breakdown of academic impact, for papers by David Witt Breakdown of academic impact, for papers by Mojca Matičič Breakdown of academic impact, for papers by Patrick Miailhes Breakdown of academic impact, for papers by Marie‐Luce Delforge Breakdown of academic impact, for papers by Marcello Piazza Breakdown of academic impact, for papers by Victoria Aramă
Rankless by CCL
2026